All news

Abbott to spin off $8.5B nutrition unit

Alpha Vantage · TipRanks · · AI-summarised by FinFlash

Abbott Laboratories shares fell 4% in pre-market trading after the company said it will separate its global Nutrition business into an independent, publicly traded company by the end of next year. The new entity, with $8.5 billion in annual sales, will focus on healthy nutrition, while Abbott concentrates on medical devices, diagnostics and established medicines.

Read original source

ABT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.